Buying your own lab

Last November, we linkurl:reported;http://www.the-scientist.com/article/display/15837/ that the owners of an upscale spa in New York State had 'offered $10 million to the University of Chicago for the Yerkes Observatory in Williams Bay, Wis. ? one of the nation's most historically important, if no longer scientifically advanced, observatories.' Well, they got it. According to a press release this week from the resort firm, Mirbeau will build a 100-room retreat and 73 small homes on the 30 acres

Written byIvan Oransky
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Last November, we linkurl:reported;http://www.the-scientist.com/article/display/15837/ that the owners of an upscale spa in New York State had 'offered $10 million to the University of Chicago for the Yerkes Observatory in Williams Bay, Wis. ? one of the nation's most historically important, if no longer scientifically advanced, observatories.' Well, they got it. According to a press release this week from the resort firm, Mirbeau will build a 100-room retreat and 73 small homes on the 30 acres surrounding the observatory. The observatory, in turn, will continue to be managed by its current owner, the University of Chicago, and will become 'a center for science and educational outreach for the wider astronomical and educational communities.' Funding will be through new room taxes and a portion of new property taxes generated from the development of the property, and the whole thing will be controlled by the Village of Williams Bay, Wisconsin. The press release doesn't say whether the university accepted the $10 million as the final offer, but with that as a starting point, why not call the NIH and see what Uncle Sam will take for a resort in the rolling hills of Bethesda?
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies